News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syros Pharmaceuticals Appoints Vicki L. Sato, Ph.D., to Board of Directors



9/5/2013 9:23:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today the appointment of Vicki L. Sato, Ph.D., to its Board of Directors. Dr. Sato is a Professor of Management Practice at Harvard Business School, and Professor of the Practice in the Department of Molecular and Cell Biology at Harvard University. She was previously President of Vertex Pharmaceuticals.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES